Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children

Area of Science:

• Pediatric Allergy and Immunology
• Pharmacology
• Clinical Medicine

Background:

• Nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity is extensively studied in adults but poorly defined in children, particularly young ones.
• While pediatricians rarely encounter severe issues, epidemiological data on NSAID hypersensitivity in children is conflicting.
• Some asthmatic children exhibit acetylsalicylic acid (ASA)-sensitive asthma with bronchoconstriction, and ibuprofen can cause respiratory issues in a small subset.

Purpose of the Study:

• To review current data on nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity in preschool children.
• To explore the potential role of acetaminophen's mechanism of action in NSAID hypersensitivity.
• To discuss the genetic and atopic factors associated with NSAID hypersensitivity in early childhood.

Main Methods:

• Literature review of published data on NSAID hypersensitivity in preschool children.
• Analysis of existing epidemiological studies and clinical observations.
• Examination of the pharmacological mechanisms, including cyclooxygenase (COX) enzyme inhibition.

Main Results:

• Bronchoconstriction after acetylsalicylic acid (ASA) challenge occurs in 0-22% of challenged asthmatic children.
• Ibuprofen at antipyretic doses can trigger acute respiratory problems in a small percentage of mild to moderate asthmatics.
• Acetaminophen's inhibition of cyclooxygenase (COX)-3 may explain adverse reactions in patients with cross-reactive NSAID hypersensitivity.

Conclusions:

• NSAID hypersensitivity in preschool children requires further definition and research.
• Genetic predisposition and atopy are strongly associated with NSAID hypersensitivity, even in very young children.
• Understanding the role of COX-3 inhibition by acetaminophen may offer insights into managing NSAID hypersensitivity in pediatric populations.